By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BiondVax Pharmaceuticals 

Science Park, 14 Einstein Street
P.O. Box 4143
Ness Ziona    74140  Israel
Phone: 972-8-9302529 Fax: 972-8-9302531


Company News
BiondVax Pharmaceuticals Announces Closing of U.S. IPO 5/15/2015 10:33:54 AM
BiondVax Pharmaceuticals Announces Pricing Of U.S. IPO Of 1,910,000 Adss And Warrants To Purchase 1,910,000 Adss 5/12/2015 7:29:25 AM
Universal Flu Vaccine Co BiondVax Pharmaceuticals Mulls NY IPO 11/24/2014 5:53:06 AM
BiondVax Pharmaceuticals To Initiate The Process For Trading The Company's Shares In The U.S. Through ADR 4/2/2014 11:17:41 AM
Priming With BiondVax Pharmaceuticals' Universal Influenza (Flu) Vaccine Broadens the Activity of Conventional Bird Pandemic Vaccine Against Emerging Strains 8/26/2013 9:04:28 AM
The Eminent Business Executive and Philanthropist Jack Rosen Joins the Board of Directors at BiondVax Pharmaceuticals 7/17/2013 8:47:22 AM
BiondVax Pharmaceuticals to Present at the First World Health Organization Meeting on Broadly Protective Influenza Vaccines on January 25th 1/15/2013 11:04:01 AM
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine 12/17/2012 11:02:37 AM
MonoSolRx LLC and BiondVax Pharmaceuticals Collaborate to Develop Oral Film Delivery of Flu Vaccine 11/7/2012 9:25:05 AM
BiondVax Pharmaceuticals's Universal Flu Vaccine Improves Existing Flu Vaccines in Elderly. In a Second Phase II Trial, the Vaccine Proves Safe and Activates Immunity to Flu 2/16/2012 9:40:53 AM